Elsevier

Neuropharmacology

Volume 33, Issues 3–4, March–April 1994, Pages 473-482
Neuropharmacology

Pharmacological characterization of the apparent splice variants of the murine 5-HT3 R-A subunit expressed in Xenopus laevis oocytes

https://doi.org/10.1016/0028-3908(94)90078-7Get rights and content

Abstract

The actions of 5-hydroxytryptamine3 (5-HT3) receptor agonists and antagonists have been determined on the recombinant murine 5-HT3 R-A and an apparent splice variant of this subunit, termed 5-HT3 R-As. When expressed in Xenopus laevis oocytes, both forms of the subunit functioned as a homo-oligomeric complex and exhibited inward current responses to bath applied 5-HT. Analysis of the 5-HT concentration-response curve obtained with either homo-oligomer gave Hill coefficients greater than two, suggesting positive co-operativity within the receptor complex. The rank order of potency of a range of 5-HT3 receptor agonists [m-chlorophenylbiguanide> 5-HT> 2-methyl-5-HT (2-Me-5-HT) ⩾ phenylbiguanide] was identical for both subunits. Indeed, with the exception of 2-Me-5-HT, for the agonists tested there was little difference across the subunits in either their potency, or the maximal current response that they elicited relative to 5-HT. Although 2-Me-5-HT exhibited a similar potency for both subunits, the maximal response evoked by this agonist at the 5-HT3 R-As subunit was much reduced when compared to the 5-HT3 R-A subunit. The 5-HT-induced current mediated by either form of the subunit was inhibited by the 5-HT3 receptor selective antagonists BRL 46470, granisetron and ondansetron and the non-selective antagonists (+)-tubocurarine, metoclopramide and cocaine in a reversible and concentration-dependent manner. These antagonists did not discriminate between the subunits and their potencies were similar to those reported previously for 5-HT3 receptors native to murine neuronal cells. These results are discussed in terms of a possible diversity of 5-HT3 receptors within a species.

Reference (33)

  • DerkachV. et al.

    5-HT3 receptors are membrane ion channels

    Nature

    (1989)
  • DownieD.L. et al.

    Enhancement by trichloroethanol of agonist-induced currents mediated by a cloned murine 5-HT3 receptor subunit (5-HT3 R-A) expressed in Xenopus oocytes

    Br. J. Pharmac.

    (1993)
  • EiseléJ.-L. et al.

    Chimaeric nicotinicserotonergic receptor combines distinct ligand binding and channel specificities

    Nature

    (1993)
  • FurukawaK. et al.

    Expression of 5-HT3 receptors in PC 12 cells treated with NGF and 8-Br-cAMP

    J. Neurophysiol.

    (1992)
  • GillC. et al.

    Modulation by divalent cations of current responses mediated by a cloned murine 5-HT3 receptor (5-HT3 R-A) expressed in HEK 293 cells

    Br. J. Pharmac.

    (1993)
  • HollmanM. et al.

    Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor

    Neuron

    (1993)
  • Cited by (48)

    • Delineation of the functional properties and the mechanism of action of TMPPAA, an allosteric agonist and positive allosteric modulator of 5-HT<inf>3</inf> receptors

      2016, Biochemical Pharmacology
      Citation Excerpt :

      These values are in good agreement with previously reported binding affinities and antagonist potencies for the compounds [19,20,25,36]. Metoclopramide exhibited an IC50 of 4.0 μM, which is in the high end of the considerable range of functional IC50 values displayed by the antagonist at 5-HT3ARs in previous studies [31,32,37,38]. Finally, the 5-HT3R NAMs PU02 and propofol displayed antagonist potencies in agreement with previously reported values [26,39,40], whereas the channel blocker picrotoxin displayed a ∼10-fold lower IC50 value at the h5-HT3AR in this assay than those reported from previous studies in oocytes [41,42].

    • The 5-HT<inf>3</inf> receptor - the relationship between structure and function

      2009, Neuropharmacology
      Citation Excerpt :

      The 5-HT3A(b) isoform lacks 6 (mouse and guinea pig), or 5 (rat) amino acid residues within the large intracellular loop linking M3 and M4. Differences in the efficacy of certain 5-HT3 receptor agonists at the two isoforms have been noted along with differential modulation by activators of protein kinase A (PKA) and protein kinase C (PKC) (Downie et al., 1994; van Hooft et al., 1997; Niemeyer & Lummis, 1999; Hubbard et al., 2000). The human isoform corresponds to the 5-HT3A(b) subunit (Belelli et al., 1995; Miyake et al., 1995).

    View all citing articles on Scopus
    View full text